Citation NR: 9729053 Decision Date: 08/21/97 Archive Date: 08/26/97 DOCKET NO. 95-22 073 ) DATE ) ) On appeal from the Department of Veterans Affairs Regional Office in No. Little Rock, Arkansas THE ISSUE Entitlement to service connection for residuals of exposure to Agent Orange. REPRESENTATION Appellant represented by: Disabled American Veterans WITNESS AT HEARING ON APPEAL Appellant ATTORNEY FOR THE BOARD Gary E. O'Connor, Associate Counsel INTRODUCTION The appellant served on active duty from July 1968 to February 1970. This case comes before the Board of Veterans’ Appeals (the Board) on appeal from a August 1994 rating decision of the North Little Rock, Arkansas, Department of Veterans Affairs (VA) Regional Office (RO). REMAND A private medical doctor, Dr. Gary L. McGrew, M.D., has indicated in the appellant’s clinical records that he has “Agent Orange dermatitis,” “Agent Orange chronic dermatitis,” or “Agent Orange disease.” He did not diagnose the appellant as having one of the diseases associated with exposure to herbicide agents. 38 C.F.R. § 3.309(e) (1996). This case is REMANDED for the following action: 1. The RO is to obtain any records relating to treatment for any skin condition (1) at the VA medical center in Memphis, Tennessee on or about 1983, and (2) by Dr. Modelevsky, the appellant’s family physician. All records or responses received to this inquiry should be associated with the claims folder. The RO should proceed with all reasonable follow-up referrals that may be indicated by this inquiry. All attempts to obtain these records which are ultimately not obtained should be documented. 2. Following this development, the veteran should be afforded a VA dermatology examination. The claims folder should be made available to the examiner for review before the examination. The examiner should determine whether there is a current skin disability, to include, but not limited to, chloracne. The examiner should render an opinion as to the likely etiology of any current skin disability. The examiner should respond to the following questions: Based upon the evidence of record, is it as likely as not that any current skin disability is due to service, including exposure to Agent Orange? Is the opinion of Dr. Gary L. McGrew, M.D. to the effect that the appellant has “Agent Orange dermatitis,” “Agent Orange chronic dermatitis,” or “Agent Orange disease” supportable? The examiner should state the reasons for the opinions and confirm that the complete file was reviewed. 3. The RO should review the VA examination report to determine if the examiner has complied with the instructions listed in paragraph 2. If the findings noted in the examination report do not comport with these instructions, the RO should return the examination report and the claims folder for corrective action. 3. The General Counsel, in representing VA before the Court, has noted that the regional office has duties. Pursuant to 38 C.F.R. § 3.655, when the claimant without good cause fails to report for examination, the claim will be denied. However, the Secretary must show a lack of good cause for failing to report. Further, VA has a duty to fully inform the veteran of the consequences of the failure to undergo the scheduled examination. The regional office must comply with all notification requirements regarding the duty to report and the failure to report for examination. This Remand also serves as notice that there is a duty to report. Upon completion of this development, the RO should readjudicate the issue of entitlement to service connection for residuals of exposure to Agent Orange. If the decision remains adverse, the RO should furnish the veteran and his representative with a Supplemental Statement of the Case, and provide an adequate opportunity for reply. The RO should thereafter return the claims folder to the Board for appellate review and consideration. This claim must be afforded expeditious treatment by the RO. The law requires that all claims that are remanded by the Board of Veterans’ Appeals or by the United States Court of Veterans Appeals for additional development or other appropriate action must be handled in an expeditious manner. See The Veterans’ Benefits Improvements Act of 1994, Pub. L. No. 103-446, § 302, 108 Stat. 4645, 4658 (1994), 38 U.S.C.A. § 5101 (West Supp. 1997) (Historical and Statutory Notes). In addition, VBA’s ADJUDICATION PROCEDURE MANUAL, M21-1, Part IV, directs the ROs to provide expeditious handling of all cases that have been remanded by the Board and the Court. See M21-1, Part IV, paras. 8.44-8.45 and 38.02-38.03. H. N. SCHWARTZ Member, Board of Veterans' Appeals 38 U.S.C.A. § 7102 (West Supp. 1997) permits a proceeding instituted before the Board to be assigned to an individual member of the Board for a determination. This proceeding has been assigned to an individual member of the Board. Under 38 U.S.C.A. § 7252 (West 1991), only a decision of the Board of Veterans' Appeals is appealable to the United States Court of Veterans Appeals. This remand is in the nature of a preliminary order and does not constitute a decision of the Board on the merits of your appeal. 38 C.F.R. § 20.1100(b) (1996). - 2 -